JP2017505772A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505772A5
JP2017505772A5 JP2016548687A JP2016548687A JP2017505772A5 JP 2017505772 A5 JP2017505772 A5 JP 2017505772A5 JP 2016548687 A JP2016548687 A JP 2016548687A JP 2016548687 A JP2016548687 A JP 2016548687A JP 2017505772 A5 JP2017505772 A5 JP 2017505772A5
Authority
JP
Japan
Prior art keywords
analog
spadin
propeptide
mixture
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016548687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505772A (ja
JP6640725B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/000338 external-priority patent/WO2015110915A2/en
Publication of JP2017505772A publication Critical patent/JP2017505772A/ja
Publication of JP2017505772A5 publication Critical patent/JP2017505772A5/ja
Application granted granted Critical
Publication of JP6640725B2 publication Critical patent/JP6640725B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2016548687A 2014-01-27 2015-01-27 ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す Expired - Fee Related JP6640725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461931954P 2014-01-27 2014-01-27
US61/931,954 2014-01-27
PCT/IB2015/000338 WO2015110915A2 (en) 2014-01-27 2015-01-27 Retro-inverso analogs of spadin display increased antidepressant effects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019174139A Division JP2020023508A (ja) 2014-01-27 2019-09-25 ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す

Publications (3)

Publication Number Publication Date
JP2017505772A JP2017505772A (ja) 2017-02-23
JP2017505772A5 true JP2017505772A5 (cg-RX-API-DMAC7.html) 2018-03-08
JP6640725B2 JP6640725B2 (ja) 2020-02-05

Family

ID=53264690

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016548687A Expired - Fee Related JP6640725B2 (ja) 2014-01-27 2015-01-27 ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す
JP2019174139A Pending JP2020023508A (ja) 2014-01-27 2019-09-25 ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019174139A Pending JP2020023508A (ja) 2014-01-27 2019-09-25 ｓｐａｄｉｎのレトロ−インベルソ類似体は増大された抗うつ作用を示す

Country Status (5)

Country Link
US (1) US10251937B2 (cg-RX-API-DMAC7.html)
EP (1) EP3099313B1 (cg-RX-API-DMAC7.html)
JP (2) JP6640725B2 (cg-RX-API-DMAC7.html)
CA (1) CA2938019A1 (cg-RX-API-DMAC7.html)
WO (1) WO2015110915A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016355236C1 (en) 2015-11-16 2022-09-22 Medincell A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
FR3057266B1 (fr) * 2016-10-11 2021-05-21 Centre Nat Rech Scient Peptides derives du propeptide ntsr3 et leur utilisation dans le traitement de la depression
FR3057267A1 (fr) * 2016-10-11 2018-04-13 Centre National De La Recherche Scientifique - Cnrs - Procede de diagnostic/determination de l'efficacite de traitement de la depression
KR102250582B1 (ko) * 2018-05-11 2021-05-12 고려대학교 산학협력단 별아교세포 특이적 수동전도도 억제약물의 스크리닝 시스템 및 이의 활용
FR3099932B1 (fr) 2019-08-13 2022-11-25 Univ Limoges Peptides dérivés de la sortiline
US20240294603A1 (en) * 2023-03-02 2024-09-05 Transdermal Biotechnology, Inc. Systems and methods for delivery of spadin for treatment of depression or other indications
US11980651B1 (en) 2023-06-21 2024-05-14 Transdermal Biotechnology, Inc. Systems and methods for treatment of hearing using dihexa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272652A1 (en) * 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
ES2380055T3 (es) * 2002-12-20 2012-05-08 H. Lundbeck A/S Modulación de la actividad de neurotrofinas; método de escrutinio
EP2077278A1 (fr) * 2007-12-21 2009-07-08 Centre National de la Recherche Scientifique (CNRS) Peptide dérivé du récepteur 3 de la neurotensine et utilisation dans le traitemement de maladies psychiatriques
JP5715045B2 (ja) * 2008-04-27 2015-05-07 ハー・ルンドベック・アクチエゼルスカベット ソルチリンに対する特異的リガンドの設計
SI2658525T1 (en) 2010-12-29 2018-04-30 Medincell Biodegradable Composites for Delivery
US20120322060A1 (en) * 2011-04-13 2012-12-20 Centre National De Le Recherche Scientifique - Cnrs - Diagnosis and monitoring treatment of psychiatric diseases with spadin and related methods
JP6134788B2 (ja) * 2012-06-27 2017-05-24 メドインセルル 疎水性組成物のための生分解性薬物送達

Similar Documents

Publication Publication Date Title
JP2017505772A5 (cg-RX-API-DMAC7.html)
TW201613958A (en) MIC-1 fusion proteins and uses thereof
EA201990298A1 (ru) Способы и композиции для лечения рака
JOP20190247A1 (ar) أجسام بيتا ببتيد النشوانية المضادة لـ N3pGlu واستخداماتها
PE20240015A1 (es) Proteinas de fusion gdf15 y usos de estas
CL2012001686A1 (es) Analogo peptidico de oxintomodulina, en donde el aminoacido c-terminal es opcionalmente amidado; composicion farmaceutica que lo comprende y su uso en la preparacion de un medicamento para el tratamiento de diabetes no insulinodependiente u obesidad.
EA201990071A1 (ru) Композиция пептидной вакцины
PH12018502465A1 (en) Mic-1 compounds and use thereof
PH12014501083A1 (en) Anticancer fusion protein
AR096162A1 (es) Péptidos terapéuticos
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
JP2016509011A5 (cg-RX-API-DMAC7.html)
EP3363458A3 (en) A peptide
PH12019550241A1 (en) Mic-1 compounds and uses thereof
CA2839298C (en) Anti-inflammatory pharmaceutical products
EP3638298A4 (en) PEPTIDIC IMMUNOGENS FROM THE C-TERMINAL END OF A PROTEIN, ALPHA-SYNUCLEIN, AND COMPOSITIONS CONTAINING IT FOR THE TREATMENT OF SYNUCLEINOPATHIES
WO2017032856A3 (en) Compounds for inducing tissue formation and uses thereof
JP2018186833A5 (cg-RX-API-DMAC7.html)
EA201790341A1 (ru) Анти-ск8 антитела для применения в лечении рака
PE20161406A1 (es) Proteinas de fusion tatk-cdkl5, composiciones, formulaciones y uso de estas
MY194448A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
SA522432563B1 (ar) نظير ببتيد أوكسينتو موديولين معالج بأسيل
NZ729514A (en) Therapeutic multi-peptides t specific immune therapy for treatment of brain metastasis
PL394618A1 (pl) Przeciwnowotworowe bialko fuzyjne
JP2016515123A5 (cg-RX-API-DMAC7.html)